Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Bone Marrow Diseases × spartalizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor, Adult 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Nasopharangeal Cancer 1 Myelodysplastic Syndromes 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Kidney Diseases 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Advanced Malignant Tumors 1 Advanced Malignant Solid Neoplasm 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Busulfan 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 ponatinib 1 pembrolizumab 1 ibrutinib 1 Quality of Life 1 Electrocardiography 1 Clinical Laboratory Techniques 1 Bone Marrow Transplantation 1 Bone Marrow Examination 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡